AbbVie has shared full results from a phase 3 trial it is hoping will persuade the FDA to approve a medicine solution for age-related far-sightedness, which is typically treated with contacts or ...

Short-sightedness (myopia) and long-sightedness (hyperopia) are usually due to a mismatch between the length of the eye, from front to back, and the combined power of the cornea –the transparent ...

We’ve known for years now that rates of short-sightedness (scientifically known as myopia) are rising globally. Some estimates even suggest that half of the world’s population will be short-sighted by ...

Parents are being warned of the rapid rise in short sightedness in children, as a third of kids now need glasses according to landmark global study. According to the research, cases among children and ...

The pandemic may be to blame for spiralling levels of short-sightedness in children, researchers revealed today. Experts have long warned it is because youngsters are spending less time outdoors and ...

Visus Therapeutics is coming for AbbVie. After ceding a big head start to AbbVie’s recently approved Vuity, Visus has posted midphase data that advance its effort to come from behind in the new market ...